1. Home
  2. TRVI vs PHIN Comparison

TRVI vs PHIN Comparison

Compare TRVI & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

SELL

Current Price

$13.31

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Logo PHINIA Inc.

PHIN

PHINIA Inc.

SELL

Current Price

$73.81

Market Cap

2.3B

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
TRVI
PHIN
Founded
2011
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.3B
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
TRVI
PHIN
Price
$13.31
$73.81
Analyst Decision
Strong Buy
Buy
Analyst Count
11
5
Target Price
$28.18
★ $84.40
AVG Volume (30 Days)
★ 1.5M
349.8K
Earning Date
11-09-2026
10-29-2026
Dividend Yield
N/A
★ 1.64%
EPS Growth
31.91
★ 84.09
EPS
N/A
★ 3.79
Revenue
N/A
N/A
Revenue This Year
N/A
$4.85
Revenue Next Year
N/A
$3.11
P/E Ratio
★ N/A
$19.35
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$51.38
52 Week High
$20.22
$86.94

Technical Indicators

Market Signals
Indicator
TRVI
PHIN
Relative Strength Index (RSI) 46.10 68.57
Support Level $13.00 $69.02
Resistance Level $13.55 $74.43
Average True Range (ATR) 0.88 2.80
MACD 0.06 0.91
Stochastic Oscillator 20.92 96.88

Price Performance

Historical Comparison
TRVI
PHIN

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

Share on Social Networks: